Bio-Rad Laboratories, Inc. (BIO.B) stock
BIO.BNYSELaboratory Analytical InstrumentsFiscal year ends December 31Also trades as BIO
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026Score 8/3055% above fair value
$379.50+0.00 (0.00%)
Close on Oct 29, 2026Market cap $10.18BP/E 46.2Yield –
Bio-Rad Laboratories pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Bio-Rad Laboratories's pe ratio was 42.8× on Oct 19, 2026, against 3.6× a year earlier. Over the last 5 years it ranged from 2.7× to 53.6×, with a median of 9.4×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Oct 19, 2026 | 42.8× | +15.5 |
| 2025 | Oct 31, 2025 | 27.2× | +23.6 |
| 2022 | Apr 29, 2022 | 3.6× | +0.2 |
| 2021 | Dec 31, 2021 | 3.4× | −1.6 |
| 2020 | Dec 31, 2020 | 5.0× | −25.4 |
| 2019 | Dec 31, 2019 | 30.4× | +24.9 |
| 2018 | Dec 31, 2018 | 5.5× | −345.5 |
| 2017 | Dec 29, 2017 | 351.0× | +293.8 |
| 2016 | Dec 30, 2016 | 57.1× | +17.6 |
| 2015 | Dec 31, 2015 | 39.5× | −4.3 |
| 2014 | Dec 31, 2014 | 43.8× | +4.1 |
| 2013 | Dec 31, 2013 | 39.7× | +23.2 |
| 2012 | Dec 31, 2012 | 16.5× | +2.0 |
| 2011 | Dec 30, 2011 | 14.6× | −4.2 |
| 2010 | Dec 31, 2010 | 18.8× | −11.0 |
| 2009 | Dec 31, 2009 | 29.8× | – |